Two Aurora Branded Medical Cannabis Products Soon To Be Available In Malta’s Pharmacies

Here’s the press release in full

EDMONTON, June 25, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that the Company, through its wholly owned German subsidiary Pedanios GmbH (“Pedanios”), has become the first licensed supplier of medical cannabis to patients in Malta. The import license issued by the Malta Medicines Authority (“MMA”) was received on June 5, 2018, and Pedanios received the necessary export license from German authorities on June 21, 2018. After Germany and Italy, Malta is the third European Union member country where Pedanios currently sells medical cannabis.

Two products, Pedanios 22/1 and 20/1, are being shipped to Malta today, and will become available in Maltese pharmacies shortly. Pedanios expects pharmacists will be able to fill patient prescriptions within approximately two weeks. These orders will include medically approved vaporization devices for patients’ consumption of Aurora cannabis products.

Market entrance in Malta was achieved through close collaboration with Aurora’s local distribution partner Cherubino Ltd. (“Cherubino”), the largest pharmaceutical wholesaler in Malta, who have over 100 years of operating history. This partnership was instrumental in navigating the rigorous legislative requirements of the MMA to supply high-quality medical cannabis to Maltese patients. Medical cannabis was initially legalized by the Maltese parliament on March 26, 2018.

Primary Sponsor

 


Karma Koala Podcast

Top Marijuana Blog